Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2025-08-20 Director's Dealing
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Final Directors Interest Notice 2 pages 291.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares and share rights, and notes the date the director ceased to be a director. This is a report of personal share transactions and holdings by a company director. The document length is short and focused solely on director share interests, which aligns with the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2025-08-20 English
Notice of Annual General Meeting 52 pages 3.0MB
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) for Little Green Pharma Ltd, detailing the date, time, virtual attendance instructions, agenda items including consideration of the Annual Report, and multiple resolutions to be voted on by shareholders. It includes procedural information about voting exclusions and prohibitions, proxy voting, and the order of the meeting. The document does not contain the actual Annual Report or financial statements but rather serves as the official notification and explanatory memorandum for the AGM. Therefore, it fits the category of AGM Information (AGM-R) rather than the Annual Report (10-K) or other categories.
2025-07-23 English
Letter to Shareholders regarding Annual General Meeting 2 pages 168.7KB
AGM Information Classification · 100% confidence The document is a Notice of Meeting for the 2025 Annual General Meeting (AGM) of Little Green Pharma Ltd. It includes details about the virtual attendance, voting procedures, proxy submission, and instructions for shareholders. It does not contain financial statements or detailed financial performance data, but rather logistical and procedural information related to the AGM. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document length is 4019 characters, which is consistent with a notice rather than a full report. Therefore, the appropriate classification is AGM-R.
2025-07-23 English
Appendix 3Y - Covering Letter 6 pages 418.1KB
Director's Dealing Classification · 100% confidence The document is an ASX announcement dated 22 July 2025, containing Appendix 3Y Change of Director Interest Notices for two directors of Little Green Pharma Ltd. It details changes in securities held by directors, including acquisitions and disposals of shares and retention share rights. The document explicitly addresses the non-disclosure of previous changes and compliance with ASX Listing Rules 3.19A and 3.19B. Appendix 3Y is a standard form used for reporting changes in directors' interests in securities. The content focuses on personal share transactions by company directors, which fits the definition of Director's Dealing filings. The document is not a full financial report, earnings release, or management report, nor is it an announcement of a report publication. Therefore, the correct classification is Director's Dealing (DIRS).
2025-07-21 English
Quarterly Activities Report and Appendix 4C 16 pages 1.9MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'JUNE 2025 QUARTERLY ACTIVITIES REPORT AND APPENDIX 4C' and contains detailed financial and operational data for the quarter ending 30 June 2025. It includes revenue figures, cash flow data, segment and product category breakdowns, market updates, and financial metrics such as net tangible assets and enterprise value. The presence of substantive financial data and analysis for a specific quarter indicates this is a comprehensive quarterly report. The document is approximately 15,000 characters long, which is consistent with a full report rather than a brief announcement. The mention of Appendix 4C, which is a standard quarterly cash flow report for ASX-listed companies, further supports classification as a quarterly report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q4 2025
2025-07-16 English
Application for quotation of securities - LGP 6 pages 19.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement for the application for quotation of securities. It details the issuance and quotation of securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue dates, and whether the securities are part of an employee incentive scheme. It is not a financial report, earnings release, or management discussion but rather a formal announcement related to capital changes and securities quotation on the exchange. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 6676 characters, which is consistent with a detailed announcement rather than a brief notice or a full report.
2025-07-15 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.